Imagine that you’re the parent of a child with a rare medical condition. You’ve spent three years and most of your savings bouncing from doctor to doctor, clinic to clinic, treatment to treatment, without uncovering any real answers. Your child’s condition has stumped some of the best practitioners in the state and country.

What if you could stop the questions and the testing and instead, doctors could survey your child’s DNA, in a test as simple as drawing blood?

Through the high-tech analysis of your child’s genome sequence, physicians could pinpoint without a doubt the genetic components of your child’s condition and ensure that the proper treatment plan was prescribed.

Read more on Business Alabama.